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Abstract
Introduction: The objective of this study was to investigate the effects of moderate-to-high intensity Nordic
walking (NW) on functional capacity and pain in fibromyalgia (FM).
Methods: A total of 67 women with FM were recruited to the study and randomized either to moderate-to-high
intensity Nordic Walking (n = 34, age 48 ± 7.8 years) or to a control group engaging in supervised low-intensity
walking (LIW, n = 33, age 50 ± 7.6 years). Primary outcomes were the six-minute walk test (6MWT) and the
Fibromyalgia Impact Questionnaire Pain scale (FIQ Pain). Secondary outcomes were: exercise heart rate in a
submaximal ergometer bicycle test, the FIQ Physical (activity limitations) and the FIQ total score.
Results: A total of 58 patients completed the post-test. Significantly greater improvement in the 6MWT was found
in the NW group (P = 0.009), as compared with the LIW group. No between-group difference was found for the
FIQ Pain (P = 0.626). A significantly larger decrease in exercise heart rate (P = 0.020) and significantly improved
scores on the FIQ Physical (P = 0.027) were found in the NW group as compared with the LIW group. No
between-group difference was found for the change in the FIQ total. The effect sizes were moderate for the above
mentioned outcomes.
Conclusions: Moderate-to-high intensity aerobic exercise by means of Nordic walking twice a week for 15 weeks
was found to be a feasible mode of exercise, resulting in improved functional capacity and a decreased level of
activity limitations. Pain severity did not change over time during the exercise period.
Trial registration: Clinicaltrials.gov identifier NCT00643006.
Introduction
Fibromyalgia (FM) is a non-inflammatory rheumatic dis-
order characterized by widespread long-lasting pain, fati-
gue, distress and difficulties in carrying out daily
activities. The prevalence of FM ranges from 1% to 3%
in the general population, increasing with age and
female sex [1]. Criteria for FM include a history of long-
lasting widespread pain and pain in 11 of the total of 18
tender points examined at manual palpation [2].
Aberrant physiological pain-processing mechanisms,
together with psychological and environmental factors,
interact in the development and maintenance of FM.
Pain, fatigue, distress and lack of knowledge about the
reasons for pain often lead to a decrease in the level of
physical activity and to impaired body functions. Body
functions are usually impaired in FM [3] and are asso-
ciated with limitations in daily activities [4]. Low-intensity
exercise, adjusted to the limitations of the patient, has
been found to be safe in FM, and is suggested to be an
important part of treatment in patients with FM. Walking
of low-to-moderate intensity has been found to be safe in
FM and to improve function [5,6] and quality of life [7]
among FM patients. Exercise in a temperate pool of
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low-to-moderate intensity has shown improvements in
walking ability [8-11], symptoms [10-13] and distress
[10,12-14] in sedentary patients with FM.
Some studies have shown that exercise of moderate-
to-high intensity improves physical function and pain in
FM [15], while others have reported that aggravation of
pain [16] or fear of it [17] hindered patients from com-
pleting a planned exercise protocol and improving func-
tional capacity. Nordic walking (NW) is a mode of
exercise that has gained popularity in Northern Europe
in recent years. NW is walking using poles, which
implies that muscles in the upper body are also acti-
vated and that the length of steps can be increased,
which results in a faster gait as compared to walking
without poles. Because of the frequent impairments in
the function of the upper and lower extremities in
patients with FM [3], it was unclear whether NW might
be a feasible mode of exercise for this population. To
our knowledge, no previous reports have described NW
in FM. The aim of this study was to investigate whether
moderate-to-high intensity NW could be a feasible exer-
cise in patients with FM and whether it could improve
functional capacity and pain in these patients. Our pri-
mary hypothesis was thus that moderate-to-high inten-
sity NW, conducted twice a week for 20 minutes for a




A randomized controlled trial (RCT) compared the
effects of two 15-week exercise programs. The experi-
mental intervention was a supervised moderate-to-high
intensity NW program twice a week for 20 minutes,
while the active comparator was a supervised low-inten-
sity walking (LIW) program once a week. Trial registra-
tion: ClinicalTrials.gov identifier NCT00643006.
The primary outcomes were the six-minute walk test
(6MWT) and the Fibromyalgia Impact Questionnaire
pain scale (FIQ Pain). Our secondary hypothesis was
that the intervention would improve aerobic capacity,
overall health status and activity limitations, the two lat-
ter variables assessed by the FIQ total score and the FIQ
Physical. The exploratory outcomes included a multidi-
mensional questionnaire concerning fatigue.
Criteria for inclusion: Women aged 20 to 60 years
with fibromyalgia, defined by the ACR 1990 criteria [2]:
a history of long-lasting generalized pain and pain in at
least 11 of 18 tender points examined by manual palpa-
tion, an ablility to manage a bicycle test at 50 watts or
more, and interest in exercising outdoors twice a week
for 15 weeks.
Criteria for exclusion: Patients not speaking or reading
Swedish, other severe somatic or psychiatric disease,
ongoing or planned physical therapy, including exercise,
and an inability to accept times for planned exercise
sessions.
Recruitment, examinations and randomization
Female patients were consecutively recruited through
newspaper advertisements, at health care centres in
West Sweden or from participation in an earlier study.
Two hundred and thirty-nine patients were assessed for
eligibility. Fifty-four patients did not fulfill the inclusion
criteria (other severe disorder n = 27, not fulfilling cri-
teria for FM n = 16, age >65 years n = 6, planned opera-
tion n = 5). Twenty-four were excluded due to
treatment in progress. Seventy-two declined to partici-
pate for time restrictions (n = 47), negative experiences
of NW (n = 4), family commitments (n = 2), not inter-
ested (n = 16) or unknown reasons (n = 3). Twenty-two
could not be contacted. A total of 67 was randomized
to the study. Figure 1 shows the participants’ flow and
reasons for being lost to follow-up.
The screening examination included verification of the
ACR 1990 criteria for FM, including a pain localisation
sheet [18], a standardized interview and examination of
tender points [2]. Patients were then referred to a base-
line examination that included a battery of question-
naires, the 6MWT and a submaximal ergometer bicycle
test. Body weight and height were measured in light
clothing without shoes, and BMI was calculated. Sixty-
seven patients completed the baseline examination,
where single-blinded examiners did not know the group
to which patient would be randomized. After comple-
tion of the baseline test the patients were randomized
by persons not involved in the examination. Randomiza-
tion was conducted by using concealed envelopes pre-
pared by the statistician. The numbered envelope was
opened together with the patient, after which the patient
was informed about the group to which she had been
randomized. A total of 34 patients was randomized to
NW and 33 to LIW. All patients were invited to a 16-
week post-test and a six-month follow-up examination.
The patients were advised to continue their baseline
medical treatment with no change throughout the 15-
week study period.
Intervention
The study was conducted in parks and forests with flat
areas and small hills in one larger (n = 32) and two
smaller (n = 14; n = 21) cities in Western Sweden. Each
exercise session lasted 40 to 45 minutes, in addition to a
five-minute stretching period. Groups of 7 to 15 patients
were supervised by two leaders at each session; there
were in all 13 exercise leaders, who were physical thera-
pists, physical therapy students or trained exercise
leaders.
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Intervention group
Patients randomized to NW participated in supervised
exercise sessions twice a week for 15 weeks. The target was
to achieve 20 minutes of moderate-to-high intensity exer-
cise. Exercise intensity was based on the subjective percep-
tion of exertion, and the patients were instructed as to how
to rate exertion on the Borg´s Rating of Perceived Exertion
(RPE) scale ranging from 6 to 20 [19]. RPE <12 is consid-
ered to correspond to <40% of the maximal heart rate,
while 12 to 13 (moderate) corresponds to 40 to 60% and
14 to 16 (heavy) to 60 to 85% of the maximal heart rate
[20]. The groups started with light exercise for 10 minutes,
ranging from 9 (very light) to 11 (fairly light) on the RPE
scale, after which they performed two-minute intervals of
moderate-to-high intensity exercise, defined as exertion
ranging from 13 to 15 on the RPE scale, alternated with
two-minute low-intensity exercise, defined as 10 to 11 on
the RPE scale. This means that the participants walked at
different speeds in small groups, and the leaders alternated
between them to provide individual instruction.
Control group
Patients randomized to the LIW participated in super-
vised exercise sessions once a week for 15 weeks. The
groups walked at a low intensity level, ranging from
9 (very light) to 11 (fairly light) on the RPE scale.
Ethics
The study was approved by the ethics committee of
Gothenburg University. Written and verbal information
was given to all patients and written consent was
obtained from all patients. The patients were informed
 
Randomized (n = 67) 
 
Allocated to Nordic Walking group (n = 34) 
    Received allocated intervention (n = 29)   
   Discontinued intervention (n = 5)  
Lost to follow up at post treatment examination (n = 4) 
   Not interested (n = 4)  
 
Lost to follow up at post treatment examination (n = 5) 
   Change of work schedule (n = 2) 
   Concomitant disorders (n = 1) 
   Increased pain (n = 1) 
   Not interested (n = 1) 
Analysed post treatment examination (n = 29) 
   Excluded from analysis (n = 0) 
 
Analysed at post treatment examination (n = 29) 
   Excluded from analysis (n = 0) 
Lost to follow up at long time follow up examination (n = 7) 
Not interested (n = 5)  
Concomitant disorders (n = 2)  
Lost to follow up at long time follow up examination (n = 6) 
Change of work schedule (n = 2)  
Increased pain (n = 1)  
Not interested (n = 1)  
Concomitant disorders (n = 1)  
Unknown reason (n = 1)  
Allocated to Low-Intensive Walking group (n = 33)  
   Received allocated intervention (n = 28)  
   Discontinued intervention (n = 5)   
 
Analysed at long time follow up examination (n = 28) 
Excluded from analysis (n = 0) 
 
Analysed at long time follow up examination (n = 26) 
Excluded from analysis (n = 0) 
 
Figure 1 Participants’ flow.
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that post-exercise pain could be felt during the first
weeks of the exercise program.
Primary outcomes
For the six-minute walk test (6MWT) the patient was
instructed to walk as quickly as possible but not to run.
The distance covered was measured in meters [21].
The FIQ Pain is a subscale (0 to 100) of the Fibro-
myalgia Impact Questionnaire (FIQ), a self-administered
questionnaire that assesses health status [22].
Secondary outcomes
The FIQ Physical (0 to 100) is a subscale of the FIQ that
assesses activity limitations. The FIQ total score assesses
health status (0 to 100) [22].
Exercise heart rate was measured with a submaximal
exercise test on a cycle ergometer (Monark 828E, Var-
berg, Sweden) with unaltered exercise intensity at base-
line and post-test [23]. The selected exercise intensity
was either 50 or 75 watts, defined after a structured
interview concerning the patient´s physical activity level
during the most recent month. The test lasted for six
minutes and the pedal frequency was 60 rpm. Heart
rate was recorded every minute using telemetry (Polar
Electro OY Kempele, Finland), the rate of perceived
exertion was assessed on Borg´s Rating of Perceived
Exertion (RPE) scale and blood pressure was measured
every second minute with a sphygmomanometer. The
exercise heart rate was defined as the mean heart value
during the fifth and the sixth minute. The subjects were
asked to refrain from tobacco, caffeine and food for two
hours before the test [24] and from carrying out heavy
exercise the day before the visit to the test station.
Diurnal variations were taken into consideration by
attempting to book the patient at the same time of day
at both tests.
Exploratory outcomes
The Multidimensional Fatigue Inventory (MFI-20) is a
self-administered questionnaire that contains 20 state-
ments about fatigue building five subscales ranging from
4 to 20 [25].
Background variables
The Leisure Time Physical Activity Instrument (LTPAI)
assesses the amount of physical activity during a typical
week. The total score is the sum of the hours [26]. The
Hospital Anxiety and Depression Scale (HADS) builds
two subscales: HADS-A for anxiety (0 to 21) and
HADS-D (0 to 21) for depression [27]. A cut-off score
of eight is suggested to indicate possible anxiety or
depression. Muscle tenderness was examined using an
algometer (Somedic Production AB, Sollentuna, Swe-
den), measured in kPa/second [28].
Local pain score (0 to 10) was assessed as the mean
value of weekly ratings of pain in the upper and lower
extremities recorded in an exercise diary.
Statistics
On the basis of the results of a previous exercise study
[10], we hypothesised that a significant between-group
difference for the 6MWT would be found in a sample
of 58 patients. Descriptive data are presented as mean,
standard deviation (SD), standard error of mean (SE) or
the number and percentage. Outcomes were evaluated
according to intent-to-treat (ITT) design.
The Mann-Whitney U-test was used to analyse the dif-
ferences in continuous variables between the two groups.
The mean of baseline and post-test values was calculated
for each individual and these means were used in group
comparisons. Fischer’s exact test was used for dichoto-
mous variables and the Mantel-Haenszel chi-two test was
used for ordinal categorical variables. Wilcoxon’s signed-
rank test was used for comparisons of continuous vari-
ables within groups, and McNemar´s test was used for
dichotomous variables. The Kruskal-Wallis test was used
for comparison of the 6MWT in the three sites.
The effect size was calculated for variables that
showed a significant change. The effect size for
between-group variables was calculated by dividing the
mean difference between change from baseline to post-
test in the intervention group and the control group by
the pooled SD for change. The mean change from base-
line to the follow-up test was divided by the SD at base-
line to calculate the effect size for follow-up variables.
An effect size of 0.20 to 0.50 was considered small, and
an effect size >0.50 was considered moderate [29].
Relationships between the variables were examined by
Spearman’s correlation coefficient. Multivariate stepwise




No significant baseline differences for age, symptom
duration, tender point count, pain localisation or phar-
macological treatment were found between the NW (n
= 34) and LIW (n = 33) groups, see Table 1. No signifi-
cant baseline differences were found for body functions,
assessed by the 6MWT, the LTPAI, work status, the
HAD-D or the education level between the two groups.
The HAD-A was found to be significantly higher in the
NW (P = 0.040) than the LIW group, see Table 1.
All patients were invited to a post-test according to an
intent-to-treat design, and 58 patients (87%) of the total
sample completed the test. The median attendance rate
at the exercise sessions was 62% (range 0 to 100%) in the
NW group and 50% (range 0 to 93%) in the LIW group.
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Internal missing values in the NW group were found for
one person, who refused to walk due to plantar fasciitis,
in the 6MWT and in a protocol in the MFI. Internal
missing data in the LIW group were found for the FIQ in
a protocol and for the MFI in two protocols.
No significant change over time was found for the
LTPAI in the NW (P = 0.09) or the LIW group (P =
0.26). The post-test score in the LTPAI in the NW
group was 6.3 (SD 4.2, range 1.0 to 19.0), while it was
5.9 (SD 6.4, range 1.0 to 29.0) in the LIW group.
Neither was any significant change (P = 1.00) found for
use of analgetics, as 76% in the NW and 79% in the
LIW group reported use of analgetics at the post-test.
No significant change (P = 0.50; P = 1.00) was found for
use of antidepressants or sedatives over time, as intake
was reported by 76% in the NW and 68% in the LIW
group at the post-test. See Table 1 for baseline values.
The mean value of the local pain score at Week 2 was
6.2 (SD 2.00, range 1.9 to 9.3) in the NW group and 6.7
(SD, 1.8, range 4.0 to 9.3) in the LIW group. The post-
test local pain score in the NW group was 5.7 (SD 2.2,
range 1.3 to 8.7) and 6.4 (SD 2.2, range 1.7 to 10.0) in
the LIW group. No significant change in the local pain
score was found over time within the groups (NW P =
0.37; LIW 0.23) or between the groups.
Primary outcomes
A significantly greater improvement (P = 0.009) was
found in the change in the 6MWT in the NW group
(37.7, SD 41.8) as compared to the LIW group (8.6, SD
Table 1 Patient characteristics at baseline in the two groups
Nordic Walking n = 34 Low intensive Walking n = 33
Mean ± SD Mean ± SD P-value
Age, years 48 ± 7.8 50 ± 7.6 0.189
Symptom duration, years 11 ± 5.4 12 ± 5.3 0.436
Pain localisation, 0 to 18 14 ± 3.1 14 ± 2.7 0.548
TP, n 15 ± 1.8 15 ± 2.2 0.554
Algometer, kPa/sec 196 ± 56.0 210 ± 64.6 0.437
LTPAI, h 5.6 ± 4.6 4.8 ± 4.3 0.270
BMI 28 ± 4.0 28 ± 4.5 0.990
HAD-A 9.8 ± 5.3 7.2 ± 4.2 0.040
HAD-D 7.6 ± 4.3 6.8 ± 3.9 0.372
n (%) n (%)
Pharmacological treatment
Analgesics, yes 28 (82%) 27 (82%) 1.000
Antidepressants/sedatives, yes 24 (70%) 21 (64%) 0.433
Beta blocks, yes 4 (12%) 3 (9%) 0.517
Education, years
≤ 9 3 (9%) 10 (30%)
10 to 12 18 (53%) 11 (33%)
>12 13 (38%) 12 (36%) 1.195
Work status
100 to 80% 8 (24%) 4 (12%)
79 to 50% 8 (24%) 11 (33%)
<50% 3 (9%) 4 (12%)
Not working 15 (44%) 14 (42%) 0.696
Sick-leave
None 31 (91%) 30 (91%)
25 to 75% 1 (3%) 3 (9%)
100% 2 (6%) 0 (0%) 0.574
Sick- or disability pension
None 13 (38%) 7 (21%)
25 to 75% 8 (24%) 13 (39%)
100% 13 (38%) 13 (40%) 0.370
P-values for the differences between the groups are given.
TP, tender point, LTPAI, Leisure Time Physical Activity Instrument, BMI, body mass index, HAD-A, Hospital Anxiety and Depression - Anxiety, HAD-D, Hospital
Anxiety and Depression - Depression, SD, standard deviation.
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42.2) (Table 2). The effect size of the 6MWT for the
intervention group compared with the control group
was 0.69. The difference between the groups was main-
tained when adjusted for HAD-A (P = 0.021). No signif-
icant baseline differences (P = 0.129) were found for the
6MWT at baseline between the three sites. Mean differ-
ence of the 6MWT between the two groups at Site 1
was 38.8 (SE 18.4), at Site 2 it was 21 (SE 25.5), and at
Site 3 it was 27.9 (SE 15.4).
The FIQ Pain did not change significantly (P = 0.626) in
the between-group analysis of the NW and LIW groups.
Secondary outcomes
A significantly higher improvement (P = 0.027) was
found for the change in the FIQ Physical (-7.9, SD 12.6)
in the NW group as compared with the control group
(-1.3, SD 15.6) (Table 2). The effect size of the FIQ Phy-
sical in the intervention group as compared with the
control group was 0.64. The FIQ Total score did not
change significantly (P = 0.064) in the between-group
analysis of NW and LIW.
A significantly larger decrease (P = 0.020) of the heart
rate in the submaximal ergometer test was found in the
NW group (-8.9, SD 12.8) as compared with the change
in the control group (-3.1, SD 9.6). The effect size of the
heart rate for the intervention group compared with the
control group was 0.51.
Exploratory outcomes
A significantly higher improvement (P = 0.031) was
found for the change in the MFI Reduced Motivation in
the NW (-1.0, SD 3.0) as compared with the LIW group
(0.9, SD 3.2) (Table 2). The effect size of the FIQ total
score in the intervention group as compared with the
control group was 0.60.
Six-month follow-up of NW
A total of 28 patients in the NW group completed the
six-month follow-up examination.
Primary outcomes. A significant improvement (P =
0.009) was found for the change of the 6MWT (20.9,
SD 52.5) in the NW group, the effect size being 0.29.
No significant improvement was found for the FIQ Pain
(P = 0.879).
Secondary outcomes. No significant improvements
were found for the FIQ Physical (P = 0.542), FIQ total
score (P = 0.249) or exercise heart rate (P = 0.232).
Explorative outcomes. A significant improvement was
found for the MFI General Fatigue (-2.1, SD 2.2,
P <0.001) and the MFI Physical Fatigue (-1.9, SD 2.5,
P = 0.001), and the effect size was 0.68 for the MFI
General Fatigue and 0.54 for the MFI Physical Fatigue.
No significant changes were found for the MFI Reduced
Activity (P = 0.743), the MFI Reduced Motivation (P =
0.084), or the MFI Mental Health (P = 0.725).
Table 2 Changes from baseline to post-test within and between the intervention group engaging in Nordic Walking
and the control group engaging in Low-intensive walking















6MWT, meter 525 (71.1) 37.7 (41.8) <0.001 522 (56.1) 8.6 (42.2) 0.105 0.009
FIQ Pain, score 63.9 (21.2) -4.0 (14.5) 0.190 71.5 (20.7) -5.3 (16.3) 0.065 0.626
Secondary outcomes
Exercise heart rate at
ergometer test, beats/minute
124.5(17.1) -8.9 (12.8) 0.001 121.1 (12.2) -3.1 (9.6) 0.079 0.020
FIQ Physical, score 42.8 (20.5) -7.9 (12.6) 0.004 41.9 (23.35) 1.3(15.6) 0.929 0.027
FIQ Total, score 61.7 (18.3) -4.8(12.3) 0.048 62.9 (18.6) 1.9(14.2) 0.374 0.064
Explorative variables
MFI, score
General Fatigue 17.0 (3.1) -0.9 (2.9) 0.091 17.3 (3.1) -0.1 (2.7) 0.972 0.116
Physical Fatigue 16.2 (3.5) -0.5 (2.8) 0.319 17.2 (3.5) -1.0 (3.6) 0.280 0.932
Reduced Activity 14.5 (4.5) -0.2 (2.8) 0.476 15.6 (4.4) -0.5 (4.0) 0.194 1.000
Reduced Motivation 11.7 (4.3) -1.0 (3.0) 0.072 10.3 (4.4) 0.9 (3.2) 0.287 0.031
Mental Fatigue 14.9 (3.5) 0.1 (2.5) 0.608 15.1 (3.9) -0.4 (2.6) 0.461 0.336
Mean values, standard deviations (SD) and P-values for changes within and between the groups are given.
aThe 6MWT was missing in a protocol, and the MFI scores in another. bThe FIQ scores were missing in a protocol and the MFI scores in two protocols. 6MWT, Six-
Minute Walk Test, FIQ, Fibromyalgia Impact Questionnaire, MFI, Multidimensional Fatigue Inventory.
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Six-month follow-up of the LIW
A total of 26 patients in the LIW completed the six-
month follow-up.
Primary outcomes. No significant improvement was
found for the 6MWT (P = 0.603) or the FIQ Pain (P =
0.412).
Secondary outcomes. No significant changes were
found for the FIQ Physical (P = 0.710), FIQ total score
(P = 0.638) or exercise heart rate (P = 0.326).
Exploratory outcomes. A significant improvement (P =
0.001) was found for the MFI General Fatigue (-2.3, SD
2.6, P <0.001) and the MFI Physical Fatigue (-2.5, SD
3.4, P = 0.001). The effect size was 0.74 for the MFI
General Fatigue and 0.71 for the MFI Physical Fatigue.
No significant changes were found for the MFI Reduced
Activity (P = 0.794), the MFI Reduced Motivation (P =
0.147), or the MFI Mental Health (P = 0.513).
Predictors of change of the 6MWT
Multivariate stepwise regression analysis was used to
study possible predictors for change in the 6MWT
(Table 3). Age, education level, group randomized to,
attendance rate, number of TPs, pain localisation, pain
duration, baseline values of the HAD-D, the HAD-A,
the FIQ total score, the LTPAI total score and the
6MWT were chosen as independent variables. Three
models appeared, and the model showing the largest
adjusted R square, which was 0.31, is presented in Table
2. This model indicates that 31% of the variability in the
6MWT was explained by the baseline value of the
6MWT, the number of TPs and the group randomized
to, P = 0.012.
When the baseline value of the 6MWT was elimi-
nated, the only predictor for change of the 6MWT was
group (P = 0.020). The adjusted R square for that model
was 0.08.
Discussion
Patients with FM that participated in a 15-week super-
vised Nordic walking program twice a week significantly
improved their functional capacity, as assessed by the
6MWT, as compared with the active comparators that
participated in low-intensive walking, as hypothesized.
This result agrees with the Cochrane review of the
effects of exercise in FM [15]. The effect size indicated a
moderate improvement of the 6MWT in the NW group
as compared with the control group. The improved out-
come in the 6MWT corresponded with the reports of
the exercise leaders, who described a successive increase
in walking speed at the exercise sessions in most of the
participants in the NW group.
A multivariate stepwise regression analysis showed
that a lower baseline capacity of the 6MWT, a lower
number of TPs and participation in NW predicted the
improvement in the 6MWT. The number of tender
points has previously been related to pain and overall
health [30]. The present study found a low association
between the number of TPs and FIQ Pain (rho 0.31, P =
0.01), the number of pain localisations (rho 0.32, P =
0.008) and the FIQ total (rho 0.27, P = 0.03). As some
patients were fast walkers, with a baseline value of the
6MWT of about 600 meters, the outcome was probably
biased by ceiling effects among those participants.
A significantly reduced heart rate was found in a sub-
maximal ergometer test in the NW group after the exer-
cise period, as compared with the change that occurred
in the control group. A test with an unaltered exercise
intensity was chosen for this study because of the com-
mon use of beta blockers and/or anti-depressants in
FM, which may affect heart rate, and since there is a
known difficulty in FM in increasing the resistance on
an ergometer bicycle [16]. The heart rate can also be
affected by diurnal variations and use of caffeine or
tobacco. Attempts were made to control these factors
by booking the patients at the same time of day and
asking them not to change their medication during the
study period and to avoid their use of tobacco, caffeine
and food two hours before the ergometer cycle test. No
documentation was made as to the prevalence of smo-
kers; a patient’s heart rate was compared only with her
own baseline values. Despite the methodological limita-
tions involved with the assessment of heart rate, the
results indicate that women with FM may decrease their
exercise heart rate by regular moderate-to-high intensity
exercise, as suggested by previous studies in the field
[31].
The second hypothesis, that exercise of a moderate-to-
high intensity would decrease overall pain more than
low-intensity walking, was not supported by this study.
The severity of pain, rated on the FIQ Pain, did not sig-
nificantly decrease over time in any of or between the
two groups, but high standard deviations indicate a
large variation among the participants. The results agree
with a recent review of exercise programs for patients
Table 3 Multivariate stepwise regression
Variable Parameter Estimator (SE) P-value
Intercept 329.7 (64.13)
6MWT -0.30 (0.08) 0.000
TPs -7.43 (2.85) 0.010
Group -26.6 (10.14) 0.012
Independent variables are: Age, education, group, attendance rate, number of
TPs, pain localisation, pain duration, baseline values of the HAD-A, the HAD-D,
the FIQ total score, the LTPAI total score and the 6MWT. The dependent
variable is change of the 6MWT.
6MWT, Six-Minute Walk Test; TP, tender point; HAD-A, Hospital Anxiety and
Depression - Anxiety; HAD-D, Hospital Anxiety and Depression - Depression;
FIQ, Fibromyalgia Impact Questionnaire; LTPAI, Leisure Time Physical Activity
Instrument; SE, standard error.
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with FM, suggesting that most patients do not experi-
ence a decrease in pain by aerobic exercise [32].
Activity limitations in daily life (the FIQ Physical)
improved significantly in the NW group, as compared
to the change in the LIW. Health status (the FIQ Total)
improved significantly in the NW group, which agrees
with a previous study of exercise in FM [11].
It was expected that there would be an increase in
post-exercise pain during the initial phase of the exer-
cise program due to dysfunctions in peripheral and cen-
tral pain mechanisms in FM [33], and a temporary
increase of pain was reported by several patients at exer-
cise sessions, not only participants in the NW group but
also participants in the LIW group. Concomitant local
musculoskeletal pain conditions in the lower extremities
were found to limit an increased walking speed among
some patients. Patients who reported disturbing post-
exercise pain were advised to reduce their walking speed
until such time that they could again increase it. One
reason for this was to try to prevent a deterioration of
the overall pain condition, which may be induced by
peripheral musculoskeletal pain [32,34].
Only one patient interrupted the exercise program due
to adverse effects of exercise. She had chronic trochan-
teritis, which deteriorated after a few exercise sessions.
On the group level, the weekly local pain scores did not
indicate differences over time between the two groups.
Pharmacological treatment did not significantly change
from baseline to post-test in any of the groups, but
some patients reported that they had temporarily
increased their use of analgesics during the first weeks
of NW before adaptation to the exercise program.
The follow-up examination indicated that the
improvement in the 6MWT was still significant in the
NW group six months after the start of the program,
although the change between follow-up and baseline
was small. Aerobic capacity no longer indicated a signif-
icant improvement. These results show that it is difficult
for patients with FM to continue exercising at a moder-
ate-to-high intensity level without supervision.
The follow-up examination showed a significant
improvement in the MFI General Fatigue and MFI Phy-
sical Fatigue, with a moderate effect size in both groups.
The results indicate that regular exercise over a longer
period of time may decrease fatigue in FM, which is in
agreement with a previous study [11]. Alternative expla-
nations for decreased fatigue might be social interac-
tions and support during the exercise sessions, fresh air,
or a positive effect of nature.
The overall aim of the NW program was to attain 20
minutes of exercise of moderate-to-high intensity,
defined by perceived exertion using an RPE scale [19].
The participants were taught to exercise at two-minute
intervals of low- and high-intensity. They walked at
different speeds since their baseline walking capacity
varied greatly. Some participants managed the predeter-
mined level of exercise well and successively increased
their walking speed, even when climbing hills, in com-
parison with those who found it difficult to comply with
the intensity of exercise, referring to pain or other dis-
abilities. The poles were also found to improve stability
and balance when walking downhill. The program
appeared to have worked well in most participants, as
shown by the positive results. Self-reported anxiety did
not appear to negatively impact the ability to exercise or
the ability to increase the walking speed.
The baseline walking capacity of the participants and
its progress was not found to differ between the three
sites.
The outcomes were analysed according to an intent-
to-treat design, implying that patients that did not
attend a session were also invited to participate in a
post-test and were investigated accordingly. Eighty-seven
percentage of the patients participated in the post-test
examination, indicating satisfactory compliance. The
median attendance rate was 62% in the NW and 50% in
the LIW sessions, a rate that can be expected in patients
with severe health problems. Reasons for absence
included concomitant disorders, such as the flu, time
limitations and pain. As patients were advised to exer-
cise in their own environment if they failed to attend a
session, the documented attendance rate might be lower
than the actual frequency of outdoor walks during the
exercise period.
High-intensity exercise is troublesome for patients with
FM. A previous study evaluating the effects of aerobic
dance described a high attrition rate and deterioration of
symptoms due to exercise-induced pain, not finding any
improvement in functional capacity [17]. Another study of
aerobic exercise found increased pain in the group enga-
ging in high-intensity exercise on a stationary bicycle
when compared to those randomized to low-intensity
exercise [16]. Compared to these two modes of exercise,
the NW program worked better. A reason may be the use
of poles, which facilitates walking and relieves the weight
load on the lower extremities. Exercising in short intervals
was also found to be a feasible mode for this patient
group, as it provided a short rest after each vigorous inter-
val. NW therefore appears to be a viable option for
patients with FM wishing to improve their functional
capacity without risking a pain flare.
In terms of clinical implications, it appears to be
important to determine the patient’s baseline capacity
before starting to exercise, and to adjust exercise for
patients to their baseline condition. If concomitant local
pain conditions in the lower extremities hinder faster
walking, patients should be recommended to start exer-
cising at a slow speed and shorter walking distance and
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then to successively increase the speed and distance.
Supervision by a health professional who teaches
patients to use the poles, helps them to adjust the inten-
sity of their exercise to their limitations and motivates
them to increase their walking speed during high inten-
sity intervals is suggested to be valuable for outcomes.
A limitation of the present study is a lack of an
untreated control group. Supervised LIW was used to
control for improvement through attention, but a third
non-treated group should be considered in future studies
to evaluate non-specific effects of exercise such as fatigue.
As earlier described, the changes in heart rate in an erg-
ometer bicycle test should be interpreted with caution in
patients with FM owing to the pharmacological treat-
ment and other factors that may affect heart rate.
Conclusions
In conclusion, a supervised 15-week NW program
designed to alternate between low and moderate-to-high
exercise intensity, was found to be a feasible mode of
exercise for patients with FM. Most patients tolerated
this mode of exercise, and pain severity did not change
significantly over time during the exercise period. The
participants in the NW program improved their func-
tional capacity and decreased their level of activity lim-
itations compared to active comparators. Thus NW
appears to be a viable option for patients with FM who
wish to improve their functional capacity by exercise
without risking a pain flare.
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